IndietroSummary Table of Infectious Diseases: Causative Agents, Transmission, Virulence, and Prevention
Guida di studio - Note intelligenti
Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.
Overview of Infectious Diseases
This study guide summarizes key infectious diseases, focusing on their causative agents, modes of transmission and prevention, unique virulence factors or signs/symptoms, vaccine availability, and other relevant clinical or epidemiological information. The information is organized in a comparative table for efficient review and exam preparation.
Disease | Causative Agent | Transmission / Prevention | Unique Virulence Factors or Signs/Symptoms | Vaccine? | Other Info (System affected, epidemiology, etc.) |
|---|---|---|---|---|---|
Respiratory Syncytial Virus (RSV) | Respiratory syncytial virus (RSV): enveloped, single-stranded RNA genome, Pneumoviridae family | Transmitted by respiratory droplets and fomites; prevention includes sanitary practices and hand washing; antibody injections for high-risk groups (especially premature infants) | Coughing, sneezing, fever; wheezing may occur | About 60 vaccine candidates in development; antibody preparations for high-risk patients | Endemic among children under age 5; dangerous in premature infants, immunocompromised, or those with chronic lung/heart conditions; most cases from fall through early spring; incubation 4–6 days; affects respiratory system |
Pertussis (Whooping Cough) | Bordetella pertussis (Gram-negative coccobacillus) | Respiratory droplets; DTaP/Tdap vaccine; isolation of infected individuals | Paroxysmal cough with "whoop" sound; pertussis toxin; catarrhal and paroxysmal stages | DTaP/Tdap (acellular pertussis vaccine) | Primarily affects children; can be severe in infants; respiratory system |
Influenza | Influenza virus (Orthomyxoviridae; segmented, negative-sense RNA) | Respiratory droplets, fomites; annual vaccination; hand hygiene | Fever, myalgia, cough, sore throat; antigenic drift and shift | Annual inactivated/live-attenuated vaccines | Seasonal epidemics; respiratory system; can cause pandemics |
Tuberculosis | Mycobacterium tuberculosis (acid-fast bacillus) | Airborne droplets; BCG vaccine (not used in all countries); isolation, treatment with multi-drug regimen | Chronic cough, hemoptysis, night sweats, weight loss; granuloma formation | BCG (Bacillus Calmette–Guérin) | Primarily affects lungs; can be latent or active; high global burden |
Chickenpox/Shingles | Varicella-zoster virus (VZV; Herpesviridae) | Respiratory droplets, direct contact; varicella vaccine; shingles vaccine for older adults | Vesicular rash (chickenpox); dermatomal rash (shingles); latency in dorsal root ganglia | Varicella (children), Zoster (adults) | Chickenpox in children; shingles in older adults; skin and nervous system |
Measles | Measles virus (Paramyxoviridae; enveloped, negative-sense RNA) | Respiratory droplets; MMR vaccine | Koplik spots, maculopapular rash, high fever, cough, coryza, conjunctivitis | MMR (measles, mumps, rubella) | Highly contagious; respiratory and integumentary systems |
Trachoma | Chlamydia trachomatis (obligate intracellular bacterium) | Direct contact, fomites, flies; improved sanitation, antibiotics | Chronic conjunctivitis, eyelid scarring, blindness | No vaccine | Leading cause of infectious blindness; affects eyes |
Rabies | Rabies virus (Rhabdoviridae; bullet-shaped, negative-sense RNA) | Animal bites (saliva); post-exposure prophylaxis (PEP) vaccine | Hydrophobia, agitation, paralysis, fatal encephalitis | Rabies vaccine (pre- and post-exposure) | Almost always fatal once symptoms appear; nervous system |
West Nile Encephalitis | West Nile virus (Flaviviridae; enveloped, positive-sense RNA) | Mosquito vector (Culex spp.); mosquito control | Fever, headache, encephalitis, meningitis in severe cases | No human vaccine | Can cause neuroinvasive disease; nervous system |
Polio | Poliovirus (Picornaviridae; non-enveloped, positive-sense RNA) | Fecal-oral; inactivated (IPV) and oral (OPV) polio vaccines | Asymptomatic or paralytic poliomyelitis | IPV, OPV | Eradicated in most countries; nervous system |
Botulism | Clostridium botulinum (Gram-positive, spore-forming anaerobe) | Foodborne (improperly canned foods), wound, infant; proper food handling | Flaccid paralysis due to botulinum toxin | No vaccine; antitoxin available | Neurotoxin; nervous system |
Hepatitis A | Hepatitis A virus (Picornaviridae; non-enveloped, positive-sense RNA) | Fecal-oral; inactivated vaccine; improved sanitation | Acute hepatitis, jaundice, fever, nausea | Hepatitis A vaccine | Liver; does not cause chronic infection |
Stomach Ulcers | Helicobacter pylori (Gram-negative, spiral-shaped bacterium) | Oral-oral, fecal-oral; hygiene, antibiotics | Gastric inflammation, peptic ulcers, urease production | No vaccine | Digestive system; risk factor for gastric cancer |
Campylobacteriosis | Campylobacter jejuni (Gram-negative, curved rod) | Contaminated food/water (especially poultry); proper cooking | Diarrhea (often bloody), abdominal cramps, fever | No vaccine | Digestive system; common cause of bacterial gastroenteritis |
Enterohemorrhagic E. coli (EHEC) | Escherichia coli O157:H7 (Gram-negative rod) | Contaminated food/water; proper food handling | Bloody diarrhea, hemolytic uremic syndrome (HUS); Shiga toxin | No vaccine | Digestive system; can cause kidney failure |
Hepatitis B | Hepatitis B virus (Hepadnaviridae; enveloped, partially double-stranded DNA) | Blood, sexual, perinatal; recombinant vaccine | Acute and chronic hepatitis, cirrhosis, hepatocellular carcinoma | Hepatitis B vaccine | Liver; can cause chronic infection |
Chlamydia | Chlamydia trachomatis (obligate intracellular bacterium) | Sexual contact; condom use, screening, antibiotics | Often asymptomatic; urethritis, cervicitis, pelvic inflammatory disease | No vaccine | Urinary/reproductive systems; most common bacterial STI |
Gonorrhea | Neisseria gonorrhoeae (Gram-negative diplococcus) | Sexual contact; condom use, antibiotics | Urethritis, cervicitis, discharge; can be asymptomatic | No vaccine | Urinary/reproductive systems; antibiotic resistance is a concern |
Trichomoniasis | Trichomonas vaginalis (flagellated protozoan) | Sexual contact; condom use, antiprotozoal drugs | Vaginitis, frothy discharge, itching | No vaccine | Urinary/reproductive systems; common non-viral STI |
HPV (Human Papillomavirus) | Human papillomavirus (non-enveloped DNA virus) | Sexual contact; HPV vaccine (Gardasil, Cervarix) | Genital warts, cervical and other cancers | HPV vaccine (Gardasil, Cervarix) | Urinary/reproductive systems; oncogenic strains |
Rocky Mountain Spotted Fever | Rickettsia rickettsii (obligate intracellular bacterium) | Tick vector (Dermacentor spp.); tick avoidance, prompt removal | Fever, headache, petechial rash, can be fatal | No vaccine | Cardiovascular/lymphatic systems; southeastern US |
Malaria | Plasmodium spp. (protozoan parasite) | Anopheles mosquito vector; bed nets, antimalarial drugs | Fever, chills, anemia, cycles of symptoms | RTS,S/AS01 (Mosquirix) in some regions | Cardiovascular/lymphatic systems; high global burden |
Lyme Disease | Borrelia burgdorferi (spirochete bacterium) | Ixodes tick vector; tick avoidance, prompt removal | Erythema migrans (bull's-eye rash), arthritis, neurological symptoms | No vaccine (human) | Cardiovascular/lymphatic, nervous, musculoskeletal systems; endemic in NE US |
Ebola | Ebola virus (Filoviridae; enveloped, negative-sense RNA) | Direct contact with body fluids; infection control, rVSV-ZEBOV vaccine | Hemorrhagic fever, high mortality, multi-organ failure | rVSV-ZEBOV (Ervebo) | Cardiovascular/lymphatic systems; outbreaks in Africa |
Key Concepts and Additional Information
Virulence Factors: Many pathogens produce toxins, enzymes, or have structural adaptations (e.g., capsules, antigenic variation) that enhance their ability to cause disease.
Vaccines: Vaccines are available for several diseases (e.g., influenza, measles, polio, HPV, hepatitis A/B, rabies, varicella, Ebola, malaria in some regions). For others, prevention relies on hygiene, vector control, or safe practices.
Transmission: Modes include respiratory droplets, direct contact, sexual contact, vectors (mosquitoes, ticks), and contaminated food/water.
Systems Affected: Diseases are classified by the primary system affected (respiratory, nervous, digestive, urinary/reproductive, cardiovascular/lymphatic, skin/eye).
Example: RSV (Respiratory Syncytial Virus)
Definition: RSV is a common respiratory virus that infects the lungs and breathing passages, especially in young children.
Transmission: Spread by respiratory droplets and contaminated surfaces (fomites).
Prevention: Emphasizes hand hygiene and, for high-risk infants, administration of monoclonal antibodies.
Symptoms: Cough, sneezing, fever, and wheezing; can be severe in infants and immunocompromised individuals.
Vaccine: No approved vaccine as of now, but several candidates are in clinical trials.
Additional info: For diseases where the original table was incomplete, causative agents, transmission, and other details were inferred based on standard microbiology knowledge.